Weight loss medication study for children with obesity
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial tests a medication for children and teens with obesity or overweight who have not been able to lose enough weight with diet and exercise alone. It aims to see if a new treatment can help them safely lose weight and improve related health problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have tried to lose weight with a diet and exercise program for at least 3 months, but it didn't work well enough.
- Your child's weight must be in the obesity range (BMI at or above the 95th percentile for their age and sex), or they must be overweight (BMI between 85th and 95th percentile) with a related health problem like high blood pressure, prediabetes, or sleep apnea.
- They cannot have had any weight-loss surgery (like gastric bypass or a gastric band) or plan to have one during the study.
- They cannot have lost more than 11 pounds (5 kg) in the last 3 months without trying.
- They cannot have type 1 diabetes or type 2 diabetes with a recent A1c blood test over 9%.
- They cannot have a family or personal history of a rare thyroid cancer called medullary thyroid carcinoma or a related condition (MEN2).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a once-weekly medication called tirzepatide to help children aged 6 to under 12 with obesity lose weight. It compares the medication to a placebo (inactive shot) to see if it safely helps with weight loss in this age group.
This clinical trial tests new treatments for adults who are overweight or have obesity. The goal is to help people lose weight and improve their health.
This study tests a once-daily pill (orforglipron) to help adolescents with obesity or overweight plus related health problems lose weight. It offers a new option for teens who have struggled to lose weight with diet and exercise alone.
This study tests an investigational medication, orforglipron, taken as a pill to help people with excess weight lose weight. It may be an option for people who have not been able to lose weight with diet alone and who also have weight-related health problems.
This trial tests an experimental medication that may help with weight loss. It aims to see how safe the drug is and how the body responds, possibly leading to a new treatment option for obesity.
This trial tests a new medicine, orforglipron, to help people with overweight who are at risk of developing weight-related health issues. It aims to see if the medicine can help with weight management and reduce risks before more serious conditions develop.
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.